Protocol No
PULM-DOMPE-REPAVID-22
Staff Member
Rahul Nanchal
Phase
III
Summary
This project is being done to see how well Reparixin works in stopping or reducing symptoms of COVID-19 and other community- acquired pneumonia (CAP) in hospitalized patients.
Objective
Reparixin as add-on to SOC to Limit Disease Progression in COVID-19 and Pneumonia
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov